Five reasons behind the decline of the industry
David Pinto answers the question What has gone wrong with the chain drug store industry in America?
David Pinto answers the question What has gone wrong with the chain drug store industry in America?
By B. Douglas Hoey, CEO of the National Community Pharmacists Association, which represents more than 18,000 independent pharmacies across the country.
By Allison Raplee, media director at Greater Than One, a healthcare media, marketing and technology agency
NACDS and the companies it represents (supermarkets and mass merchants with pharmacies as well as chain drug stores) are tackling those problems head-on, aggressively promoting policy changes that will mitigate the financial challenges facing the industry.
David Pinto writes that chain drug retailing in America has been in decline for some considerable time. Many factors must share the blame — but NACDS is not among them.
By Betty Pio, Laura Bowen, Sarah Scolnic and Christi Rich
By Kristin Hornberger, executive vice president and practice leader in wellness and homecare at Circana
By Jacqueline Flam, senior vice president of beauty, drug and OTC for NielsenIQ
By Dave Wendland, vice president of strategic relations and a member of the HRG owner group
By Todd Huseby, partner at Kearney, a global management consulting firm, and leads its Consumer Healthcare practice
By Andrea Leigh, founder and chief executive officer of the Allume Group
By Lari Harding, senior vice president of industry affairs and strategic partnerships at Inmar Intelligence
Brian Owens, managing director of strategy and insights at BAV Group.
By Darpan Seth, chief executive officer of Nextuple, an omnichannel order management advisory and software firm
Das Pattathil, chief executive officer of OnePint.ai
By Bradley Keefer, chief revenue officer at Keen Decision Systems